Zenas BioPharma Ratios (2023-2026) | ZBIO

Ratios Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) 71.25%-1,130.68%-337.78%
EBIT Margin (Quarter) 71.25%-1,112.46%-373.30%
EBITDA Margin (Quarter) 71.23%-1,049.26%-336.26%
Operating Margin (Quarter) 71.25%-1,112.46%-373.30%
Net Margin (Quarter) 71.25%-1,130.68%-335.73%
FCF Margin (Quarter) -772.56%-370.69%
Efficiency
Assets Average (Quarter) 386.70M351.87M313.43M307.55M352.83M565.66M
Equity Average (Quarter) -213.98M-239.11M-270.64M35.33M335.95M298.39M261.97M218.03M219.29M288.99M
Invested Capital (Quarter) -202.23M-225.72M-252.50M-288.78M359.44M312.46M284.32M239.63M196.43M242.14M335.83M
Asset Utilization Ratio (Quarter) 0.010.040.050.050.03
Leverage & Solvency
Interest Coverage Ratio (Quarter) -210.19
Debt to Equity (Quarter) 0.370.320.21
Debt Ratio (Quarter) 0.230.200.10
Equity Ratio (Quarter) -3.310.890.840.850.820.610.630.45
Times Interest Earned (Quarter) -210.19
Valuation
Enterprise Value (Quarter) -72.31M-56.86M-37.24M-184.02M-360.13M-350.77M-312.38M-273.28M-290.88M-343.19M-717.21M
Return Ratios
Return on Sales (Quarter) 0.01%-0.03%-0.11%-0.03%-0.12%-0.13%-0.39%
Return on Capital Employed (Quarter) -49.75%-57.36%-72.68%-78.66%-132.01%-83.86%
Return on Invested Capital (Quarter) -0.02%
Return on Assets (Quarter) 0.00%0.00%-0.01%-0.01%-0.01%-0.01%
Return on Equity (Quarter) 0.00%-0.04%0.00%-0.01%-0.01%-0.01%-0.02%-0.02%